CRYSVITA DIN 02483629
Health Canada record
| Active ingredient(s) | BUROSUMAB 10 MG |
|---|---|
| Dosage form | Solution |
| Route | Subcutaneous |
| Schedule | SCHEDULE D; PRESCRIPTION |
| Class | Human |
| ATC | M05BX05 BUROSUMAB |
| Original market date | 28-Jan-2019 |
| Current status date | 30-Nov-2022 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing BUROSUMAB
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02483637 | CRYSVITA | KYOWA KIRIN, INC. | Solution | BUROSUMAB 20 MG | Marketed |
| 02483645 | CRYSVITA | KYOWA KIRIN, INC. | Solution | BUROSUMAB 30 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 27689 | 2022-02-28 | New Drug Submission (NDS) | Administrative ¿ Manufacturer Name Change |
| 21604 | 2018-12-05 | New Drug Submission (NDS) |